logo

For the Inventor, By the Inventor

Madrid, Spain

Carlos Lamas Peteira

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Lamas Peteira. Retrieved from https://idiyas.com/inventor/carlos-lamas-peteira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal7 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 1997-1999

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5869691 - Aminoalkyl-indoles (1999-02-09),
2. 5861410 - Tetrahydro-beta-carbolines (1999-01-19),
3. 5861409 - Tetrahydro-beta-carbolines (1999-01-19),
4. 5861408 - Tetrahydro-Beta-Carbolines (1999-01-19),
5. 5663178 - Tetrahydro-beta carbolines (1997-09-02),
6. 5643916 - Tetrahydro-beta-carbolines (1997-07-01),
7. 5629317 - Tetrahydro-beta-carbolines (1997-05-13),

Title: Innovations by Carlos Lamas Peteira

Introduction

Carlos Lamas Peteira is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of central nervous system activity through his innovative research and patents. With a total of 7 patents, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents are the developments related to aminoalkyl-indoles and tetrahydro-beta-carbolines. The present invention provides novel tetrahydro-beta-carboline compounds that exhibit useful central nervous system activity. Additionally, it includes tetrahydro-beta-carboline related compounds that serve as useful intermediates and possess beneficial central nervous system activity. The invention outlines formulations and methods for utilizing these novel compounds, which are particularly effective for modulating a 5-HT.sub.2B receptor.

Career Highlights

Carlos Lamas Peteira is currently associated with Eli Lilly and Company, where he continues to advance his research in pharmacology. His work has been instrumental in developing new therapeutic approaches for various neurological conditions.

Collaborations

Throughout his career, Carlos has collaborated with esteemed colleagues such as James E Audia and Stephen Richard Baker. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Carlos Lamas Peteira's innovative contributions to the field of central nervous system activity highlight his role as a leading inventor. His patents and ongoing research continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…